CLINICAL_TRIALS
trial_result
· 2009-03-12
Clinical Trial Update: Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder [Phase 3]
Summary
Phase 3 clinical trial assessing the efficacy and safety of SR58611A in adults with major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED